Sagimet (SGMT): Rega marang dodolan

Logo korporat perusahaan Sagimet (SGMT)

The current P/S ratio demonstrates the financial stability of Sagimet Biosciences (SGMT), where the 50.90 indicator determines the metric's value. Stability is supported by sufficient capital and the partnership potential of its molecules. Success is based on the creation of an ecosystem of targeted fat degradation inhibitors. Efficiency is confirmed by unique developments in fatty acid synthase for the therapy of liver diseases.

Sagimet Biosciences Inc. - Multiplikator P/S SGMT (periode 26.03.2024 - 16.11.2024)

Rincian metrik lan analitis perusahaan sagimet.com (SGMT)

Analisis fundamental perusahaan:SGMT, Sagimet Biosciences Inc.
Barang utama Sagimet Biosciences

The P/S ratio compares the market value of Sagimet Biosciences (SGMT) to its annual revenue, allowing for the determination of the premium paid per unit of generated income and the identification of abnormal valuation deviations from fundamentals. By analyzing the current P/S level, an investor can assess the asset's resilience, considering the independence of the company's biotechnological cycle from macroeconomic shocks and the steady interest in innovative drugs.

Perusahaan pesaing

Rasio rega marang pendapatan ASND (Ascendis Pharma AS)|Rasio rega marang pendapatan madrigalpharma.com MDGL|Corcept Therapeutics Corp (CORT) - Rega marang dodolan|RYTM - Rasio rega marang pendapatan|AKRO: Rasio rega marang pendapatan|MTSR: Multiplikator P/S|MLTX - Koefisien rega marang pendapatan|Rasio rega marang pendapatan Crinetics Corp|NewAmsterdam Pharma Corp (NAMS) - Koefisien rega marang pendapatan|Rasio rega marang pendapatan soleno.life (SLNO)|Kapitalisasi marang pendapatan Amicus Therapeutics FOLD|Rasio kapitalisasi pasar marang pendapatan 89bio Inc|Multiplikator P/S Agios Pharmaceuticals, Inc. AGIO|GPCR: Kapitalisasi marang pendapatan|Koefisien rega marang pendapatan MiMedx Corp MDXG|RZLT (Rezolute Corp) - Kapitalisasi marang pendapatan|Rasio kapitalisasi marang pendapatan LXRX|MBX (MBX Biosciences) - Multiplikator P/S|Kapitalisasi marang pendapatan Altimmune Inc (ALT)|Kapitalisasi marang pendapatan AARD (Aardvark Therapeutics Corp)|BioAge Labs Inc. (BIOA) - Multiplikator rega marang pendapatan|Multiplikator P/S BMEA (Biomea Fusion Corp)|quincetx.com (QNCX) - Rega marang dodolan|GUTS - Rasio rega marang pendapatan|Rega marang dodolan vTv Therapeutics|ATPC (agapeatpgroup.com) - Kapitalisasi marang pendapatan|Rasio kapitalisasi marang pendapatan PLUR|Kapitalisasi marang pendapatan SYBX|LPCN: Rasio kapitalisasi pasar marang pendapatan|Multiplikator P/S MTNB|SPRB - Rega marang dodolan|Multiplikator P/S GLTO (Galecto Corporation)|Rasio kapitalisasi pasar marang pendapatan CTCX|Lumos Therapeutics - Multiplikator P/S|ONVO: Rasio rega marang pendapatan|Radius Recycling (RDUS) - Rasio rega marang pendapatan